These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12083328)

  • 61. [Sustained efficacy of alpha-interferon therapy combined with Yixuesheng Capsule in treatment of chronic hepatitis B].
    Mao Q; Su Y; Wu C; Duan Z; Tang J; Gu C; Liang H; Yang J; Huang L; Zheng Y; Wang M; Gong X
    Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(4):537-40. PubMed ID: 22667159
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The impact of antiviral therapy on virus-specific T-cell reactivity in patients with chronic hepatitis B].
    Feng X; Yan HP; Liao HY; Liu YM; Huang YL; Zhang GY; Lin F; Zhang X; Zhao Y; Zhang HP; Wang S; Wang Y
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):739-42. PubMed ID: 22781352
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection.
    Marrone A; Zampino R; Luongo G; Utili R; Karayiannis P; Ruggiero G
    Intervirology; 2003; 46(4):222-6. PubMed ID: 12931030
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relationship between the serum alanine aminotransferase level at the end of interferon treatment and histologic changes in wild-type and precore mutant hepatitis B virus infections.
    Bayraktar Y; Koseoglu T; Temizer A; Kayhan B; Van Thiel DH; Uzunalimoglu B
    J Viral Hepat; 1996 May; 3(3):137-42. PubMed ID: 8871872
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical significance of changes in serum hepatitis B virus DNA titer in patients with chronic hepatitis B treated with interferon.
    Hwang SJ; Lu RH; Wang YJ; Chu CW; Wu JC; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):1-7. PubMed ID: 10645044
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Chemotherapy with concomitant IFN treatment in three HBV carriers (mutant strain) with malignant lymphoma].
    Niitsu N; Nakayama M; Umeda M
    Rinsho Ketsueki; 1995 Aug; 36(8):780-5. PubMed ID: 7563613
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intramuscular natural beta interferon in the treatment of chronic hepatitis B: a multicentre trial. Italian Hepatitis B Study Group.
    Capalbo M; Palmisano L; Bonino F; Pellas C; Maset J
    Ital J Gastroenterol; 1994 Jun; 26(5):238-41. PubMed ID: 7919465
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B.
    Barth H; Klein R; Berg PA; Wiedenmann B; Hopf U; Berg T
    Hepatogastroenterology; 2001; 48(38):553-5. PubMed ID: 11379352
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected].
    You J; Zhuang L; Cheng HY; Yan SM; Qiao YW; Huang JH; Tang BZ; Ma YL; Wu GB; Qu JY; Wu RX
    J Chin Med Assoc; 2005 Feb; 68(2):65-72. PubMed ID: 15759817
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha].
    Deng L; Zhou Y; Peng X; Deng H; Deng Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():66-7. PubMed ID: 11509145
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A comparative study of Phyllanthus amarus compound and interferon in the treatment of chronic viral hepatitis B.
    Xin-Hua W; Chang-Qing L; Xing-Bo G; Lin-Chun F
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):140-2. PubMed ID: 11485076
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The relationship between alpha-IFN anti-virus treatment and HLA-DRB1*11 gene mononucleotide polymorphism].
    Chang JB; Zhou ZX; Xue R; Zhu GS; Tian YL; Zhao W
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):646-8. PubMed ID: 18822201
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The assessment of nutritional status in children with chronic hepatitis B treated with interferon alpha].
    Lebensztejn DM; Zagórecka E; Kaczmarski M; Piotrowska-Jastrzebska J
    Pol Merkur Lekarski; 2001 Jul; 11(61):29-31. PubMed ID: 11579826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-HBV vaccination before therapy with interferon (IFN) in chronic B hepatitis.
    Fruttaldo L; Schettino G; Mongiò F
    Eur Rev Med Pharmacol Sci; 1997; 1(6):197-201. PubMed ID: 9718855
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interferon: a meta-analysis of published studies in pediatric chronic hepatitis B.
    Vajro P; Migliaro F; Fontanella A; Orso G
    Acta Gastroenterol Belg; 1998; 61(2):219-23. PubMed ID: 9658614
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The treatment of chronic viral hepatitis with recombinant alpha-2 interferon: meta analysis and clinical contribution].
    Raffa S; Albiani B; Allegritti A; Fontana M; Loria C; Manzi P; Sottili S; Grassi M
    Clin Ter; 1997 Oct; 148(10):421-35. PubMed ID: 9470304
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-α among naïve chronic hepatitis B patients?
    Alavi-Moghaddam M; Alavian SM; Aalaei-Andabili SH; Eslami-Far A
    Vaccine; 2011 Nov; 29(48):9093-7. PubMed ID: 21893143
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis B.
    Alexopoulou A; Owsianka AM; Kafiri G; Dourakis SP; Carman WF; Hadziyannis SJ
    J Hepatol; 1998 Sep; 29(3):345-51. PubMed ID: 9764979
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Involvement of dynamic HBeAg quantitation and response during chronic hepatitis B treatment].
    Lun XY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):295-7. PubMed ID: 23189849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.